Protocol for Life Balance, Phosphatidyl Serine 300mg softgels, 50 count bottle, UPC…
Now Foods recalled this product and the FDA reported the enforcement action on 14 February 2024 as Class III. The recall was initiated by the firm. Amount of Phosphatidyl Serine in product is less than stated on the label
The record
Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.
Product
Protocol for Life Balance, Phosphatidyl Serine 300mg softgels, 50 count bottle, UPC 707359123922. NOW Foods, Phosphatidyl Serine 300mg softgels, 50 count bottle, UPC 733739023926.
UPC
707359123922
Reason for recall
Amount of Phosphatidyl Serine in product is less than stated on the label
Nationwide and exported to China, Kazakhstan, Czech Republic, Portugal, Kyrgyzstan, Slovakia
Initiated
10 January 2024
Reported by FDA
14 February 2024
Terminated
16 December 2025
Firm notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Product codes
Protocol Lot Number: 3309194 Best By 08/2025 Protocol Lot Number: 3316624 Best By 09/2025 NOW Lot Number: 3309243 Best By 08/2025 NOW Lot Number: 3316650 Best By 09/2025
Reading this record
Five things about this record are not in the record itself, and each one changes how it should be read.
Class III means the FDA judged that the product was unlikely to cause harm but violated FDA labelling or manufacturing regulation. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
This record is the only one the FDA opened for its recall event, so it covers a single product code.
The recall ran for 23 months, from 10 January 2024 to termination on 16 December 2025. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
The FDA published the enforcement report 5 weeks after the firm began the recall.
Recalls of a dietary supplement run a median of 15 months, so this one was longer than usual for its category. Dietary supplements are regulated under their own good manufacturing practice rule, 21 CFR part 111, and they are the only food category where the dominant recall reason is an ingredient that was never declared because it is a pharmaceutical.
These are the closest records in the corpus: the same kind of food. Unlike the firm’s own records below, they come from different companies, which is what makes them a pattern rather than a history.
NOW Health Group Inc. initiated a voluntary recall of NOW s Vitamin B-50 mg 100 Veg Caps product code 0420 because it is mislabeled as Vitamin B-50 mg 100 Veg Caps.
Product's supplement fact panel incorrectly states that the product contains 75 mg (milligrams) of Molybdenum, when it actually contains 75 mcg (micrograms).
Behind every recall is a clause somebody has to produce evidence for at their next audit. Krolda maps supplier documents to the clause they satisfy in FSSC 22000, IFS Food and 21 CFR 117, and routes the corrective action when the evidence is missing.
Recall records come from the openFDA food enforcement API, published by the U.S. Food and Drug Administration in the public domain. Krolda adds the hazard classification and the clause mapping; neither is an FDA determination. Always check the FDA notice before acting on a recall.
